Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry

NCT: NCT07732686 · NOT_YET_RECRUITING

NCT IDNCT07732686
StatusNOT_YET_RECRUITING
SponsorUniversity of Oklahoma (OTHER)
First posted
Last updated

Brief Summary

The purpose of this clinical trial is to evaluate whether volatile organic compound (VOC) signatures detected in the breath of patients with cancer can serve as a potential screening tool for the early detection of cancer.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑